Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma
Xinhua Wang(Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Tian Li(Xuzhou Central Hospital), Zhi‐Yuan Zhou(Tsinghua University), Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Ken H. Young(Duke Medical Center), Xiangli Liu(First Affiliated Hospital of Zhengzhou University), Shuxia Guo(Shihezi University), Liqun Zou(Sichuan University), Jianqiu Wu(Jiangsu Cancer Hospital), Wencai Li(First Affiliated Hospital of Zhengzhou University), Linan Zhu(First Affiliated Hospital of Zhengzhou University), Xiaolong Wu(First Affiliated Hospital of Zhengzhou University), Huizheng Bao(Jilin Province Tumor Hospital), Yi Lü(Shanghai University of Traditional Chinese Medicine), Yingjun Wang(South China University of Technology), Jieming Zhang(Lymphoma Research Foundation), Xin Li(China Medical University), Lei Zhang(Union Hospital), Lihong Liu(Hebei Medical University), Meng Dong(First Affiliated Hospital of Zhengzhou University), Liling Zhang(Union Hospital), Hong‐Wei Xue(South China Agricultural University), Jingjing Wu(Beijing Tian Tan Hospital), J Y Li(Fudan University Shanghai Cancer Center), Jiaqin Yan(First Affiliated Hospital of Zhengzhou University), Zhenchang Sun(First Affiliated Hospital of Zhengzhou University), Hui Yu(First Affiliated Hospital of Zhengzhou University), Xiaorui Fu(First Affiliated Hospital of Zhengzhou University), Liping Su, Yu Chang(Jilin University), Xudong Zhang(First Affiliated Hospital of Zhengzhou University), Feifei Nan(First Affiliated Hospital of Zhengzhou University), Ling Li(First Affiliated Hospital of Zhengzhou University), Minrui Ma(First Affiliated Hospital of Zhengzhou University), Mengjie Ding(First Affiliated Hospital of Zhengzhou University), Yanzhen Guo(First Affiliated Hospital of Henan University of Science and Technology), Xiaoyan Feng(Academy of Military Medical Sciences), Jinghua Wang(Beijing Tongren Hospital), Cunzhen Shi(First Affiliated Hospital of Zhengzhou University)
Cited by 61
Related Papers
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
|Journal of Clinical Oncology|2012|682
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
|Journal of Clinical Oncology|2015|418